Render Target: STATIC
Render Timestamp: 2024-12-20T10:58:32.598Z
Commit: f2d32940205a64f990b886d724ccee2c9935daff
XML generation date: 2024-11-19 16:31:08.889
Product last modified at: 2024-12-06T23:15:07.958Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

TRIM21 (F6K7J) Rabbit mAb #74400

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 50
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50

    Protocol

    Specificity / Sensitivity

    TRIM21 (F6K7J) Rabbit mAb recognizes endogenous levels of total TRIM21 protein.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human TRIM21 protein.

    Background

    Tripartite motif-containing protein 21 (TRIM21) is a cytosolic antiviral protein that is induced by interferons (IFNs) and acts as a cytosolic IgG receptor (1,2). TRIM21 is an activator of the innate immune system and targets antibody-bound virions to the proteasome via its E3 ubiquitin ligase activity, leading to degradation of the virions in the cytosol (3,4). Interestingly, TRIM21 has also been shown to negatively regulate pathogen-induced IFN production through the polyubiquitin-mediated degradation of multiple targets, including IRF3, IRF7, and DDX41 (5-7).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.